BioSpace News Archive

National Osteoporosis Foundation (NOF), the nation’s leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organization’s commitment to delivering quality educational programming for patients and healthcare professionals

Awareness programs by non-profit organization about the actinic keratosis treatment have increased the awareness level among the people about the actinic keratosis treatment in developed economies, which is consequently expected to increase the value of actinic keratosis treatment market

Addus HomeCare Corporation will participate in the Credit Suisse 27th Annual Healthcare Conference, which takes place November 12-15, 2018, in Scottsdale, Arizona.

Imcyse, who develop active specific immunotherapies for the treatment and prevention of severe chronic diseases, today announces the successful enrolment of 41 patients with recent-onset type 1 diabetes into its first-in-human Phase 1b study.

Alligator Bioscience today announces that it will receive payments of more than USD 3.5 million under its collaboration agreement with the South Korean company AbClon Inc.

BioInvent International AB (OMXS: BINV), and Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced they will be presenting two back-to-back posters featuring positive data supporting their ongoing collaboration to develop a novel oncolytic virus encoding for an anti-CTLA-4 antibody at the annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held November 7-11 in Washington, D.C.

Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, presents its broad viral vector expertise and their potential to transform the fight against cancer at the annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held November 7-11 in Washington DC (USA).

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the safety and efficacy data from the LUTONIX® Drug-Coated Balloon (DCB) IDE, level 1 clinical trial for a below-the-knee (BTK) indication.

MassRoots, Inc. (“MassRoots” or the “Company”) (OTCQB: MSRT), is exploring a potential expansion of its business offerings, including MassRoots for Business™ , to the Missouri, Utah and Michigan regulated cannabis markets following the success of ballot initiatives in the 2018 elections.

Ismael Cala, life and business strategist, lecturer and author of eight bestsellers on themes of leadership and emotional intelligence, is presenting in November four new programs on his podcast dMENTE Positivo, a space devoted to awakening awareness and personal growth.